| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/24/2005 | WO2005025496A2 Aliphatic pyrazinoylguanidine sodium channel blockers |
| 03/24/2005 | WO2005025492A2 Novel compositions, pharmaceutical compositions, and methods for the treatment and prevention of heart disease |
| 03/24/2005 | WO2005025490A2 Novel polyol macrolide antitumor-antibiotics from the novel marine actinomycete strain cnq140 |
| 03/24/2005 | WO2005025488A2 Methods for the controlled delivery of pharmacologically active compounds |
| 03/24/2005 | WO2005025487A2 Oligonucleotides targeting prion diseases |
| 03/24/2005 | WO2005025410A2 Formulations and methods for treating breast cancer with morinda citrifolia and methylsulfonymethane |
| 03/24/2005 | WO2005019220A3 Substituted imidazo[1,2-a]pyrazines as modulators of kinase activity |
| 03/24/2005 | WO2005016325A3 CRISTALLINE ZIPRASIDONE HCl AND PROCESSES FOR PREPARATION THEREOF |
| 03/24/2005 | WO2005012870A3 Improved aminodextran compositions and conjugates and methods of making and using them |
| 03/24/2005 | WO2005011657A3 Piperazine derivatives and their use as therapeutic agents |
| 03/24/2005 | WO2005011655A3 Pyridazine derivatives and their use as therapeutic agents |
| 03/24/2005 | WO2005011614A3 Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anti-ige antibody for treatment of asthma or chronic obstructive pulmonary disease |
| 03/24/2005 | WO2005011598A3 Leukemia treatment method and composition |
| 03/24/2005 | WO2005011597A3 Compounds and compositions as protein kinase inhibitors |
| 03/24/2005 | WO2005010315A3 Performance aid for pesticide or repellent compositions |
| 03/24/2005 | WO2005009419A3 Use of 5-methoxytryptamine as a cardioprotective agents |
| 03/24/2005 | WO2005009411A3 Particles containing an active agent in the form of a co-precipitate |
| 03/24/2005 | WO2005009348A3 Substituted purine derivatives |
| 03/24/2005 | WO2005009331A3 Use of a cosmetic or pharmaceutical composition, comprising a lupeol-rich extract as an active ingredient for stimulating the synthesis of heat shock proteins |
| 03/24/2005 | WO2005007648A3 Biaryl piperazinyl-pyridine analogues |
| 03/24/2005 | WO2005007141A3 Ubiquitin ligase inhibitors and methods related thereto |
| 03/24/2005 | WO2005005456A3 Peptide deformylase inhibitors |
| 03/24/2005 | WO2005002553A3 Fluconazole capsules with improved release |
| 03/24/2005 | WO2005000806A3 Ligands for nicotinic acetylcholine receptors, and methods of making and using them |
| 03/24/2005 | WO2005000308A3 Methods of identifying hcv ns5b polymerase inhibitors and use against hepatitis c |
| 03/24/2005 | WO2005000238A3 Use of selective cyclooxygenase-2 inhibitors for the treatment of endometriosis |
| 03/24/2005 | WO2005000212A3 Method for treating diseases using hsp90-inhibiting agents in combination with nuclear export inhibitors |
| 03/24/2005 | WO2004113335A3 Pyridino[1,2-a]pyrimidin-4-one compounds as anticancer agents |
| 03/24/2005 | WO2004112801A3 Compositions comprising zd6126 together with 5-fu, cpt-11 or 5-fu and cpt-11 having vascular damaging activity for treating e.g. colorectal cancer |
| 03/24/2005 | WO2004112505A8 Use of isomalt (mixture of 1,6 gps and 1,1 gpm) as a prebiotic for the production of a medicament used for the treatment of intestinal diseases, among other things |
| 03/24/2005 | WO2004110497A3 Mitomycin conjugates cleavable by thiols |
| 03/24/2005 | WO2004110417A3 Compositions for the enhanced treatment of depression |
| 03/24/2005 | WO2004110379A3 A1 adenosine receptor antagonists |
| 03/24/2005 | WO2004110352A3 Compounds having activity in increasing ion transport by mutant-cftr and uses thereof |
| 03/24/2005 | WO2004109290A3 Methods for identifying modulators of kinesin activity |
| 03/24/2005 | WO2004108635A3 Mixed zeaxanthin ester concentrate and uses thereof |
| 03/24/2005 | WO2004106293A3 Oxazolyl - and thiazolyl - purine based tricyclic compounds. |
| 03/24/2005 | WO2004105701A3 Compositions and methods for symptomatic relief |
| 03/24/2005 | WO2004103310A3 Methods and compositions for the treatment of metabolic disorders |
| 03/24/2005 | WO2004103280A3 Seaweed extract composition for treatment of diabetes and diabetic complications |
| 03/24/2005 | WO2004103154A3 Treatment of gastrointestinal dysfunction and related stress with an enantiomerically-pure (r) 2,3-benzodiazepine |
| 03/24/2005 | WO2004100947A3 Novel chemical compounds |
| 03/24/2005 | WO2004100889A3 Cosmetic compositions and methods for using same to improve the aesthetic appearance of skin |
| 03/24/2005 | WO2004099279A3 Heat activated tertiary amine urethane catalysts |
| 03/24/2005 | WO2004098618A3 Strontium combinations for prophylaxis/treatment of cartilage and/or bone conditions |
| 03/24/2005 | WO2004098495A3 Medical devices and methods for inhibiting proliferation of smooth muscle cells |
| 03/24/2005 | WO2004098494A3 Compounds, compositions, and methods |
| 03/24/2005 | WO2004096231A3 Use of piperazine phenothiazine derivatives in the manufacture of a medicament with neuroprotector and/or neurotrophic effects on cns and/or pns |
| 03/24/2005 | WO2004096195A3 Use of ppar-gamma agonists as anti-infective agents |
| 03/24/2005 | WO2004096135A3 Inhibitors of akt activity |
| 03/24/2005 | WO2004096116A3 Diazabicyclononene derivatives |
| 03/24/2005 | WO2004094468A3 Method for identifying an anti-streptococcal agent and its use for treating streptococcal infections |
| 03/24/2005 | WO2004094391A3 Process for the preparation of valsartan and intermediates thereof |
| 03/24/2005 | WO2004094371A3 Heterocyclic cyclopentyl tetrahydroisoquinoline and tetrahydropyridopyridine modulators of chemokine receptor activity |
| 03/24/2005 | WO2004093918A3 Peg-wortmannin conjugates |
| 03/24/2005 | WO2004091546A3 Central nervous system stimulant and opioid antagonist combinations |
| 03/24/2005 | WO2004091535A3 Methods of administering estrogens and progestins |
| 03/24/2005 | WO2004091528B1 Delivery systems of homogeneous thermoreversible alginate films |
| 03/24/2005 | WO2004091496A3 Lysophosphatidic acid analogs and inhibition of neointima formation |
| 03/24/2005 | WO2004091489A3 Topical blood pressure composition |
| 03/24/2005 | WO2004089922A3 Calcium channel inhibitors comprising benzhydril spaced from piperazine |
| 03/24/2005 | WO2004087648A3 Stabilized phenytoin containing composition |
| 03/24/2005 | WO2004087075A3 Compositions and methods for treating cancer |
| 03/24/2005 | WO2004085451A3 Office products containing antimicrobial agent |
| 03/24/2005 | WO2004085421A3 Bioreductively-activated prodrugs |
| 03/24/2005 | WO2004084645A3 Use of allicin as preservative, as disinfectant, as antimicrobial or as biocidal agent |
| 03/24/2005 | WO2004083450A3 Hyperbranched dendron and methods of synthesis and use thereof |
| 03/24/2005 | WO2004082702A8 Use of low molecular weight thrombin inhibitors in cholesterol-lowering therapy |
| 03/24/2005 | WO2004082609A3 Composition and method for appetite and carving suppression and mood enhancement |
| 03/24/2005 | WO2004080583A3 PROCESS FOR THE PREPARATION OF threo-METHYLPHENIDATE HYDROCHLORIDE |
| 03/24/2005 | WO2004080382A3 Novel compositions containing fentanyl |
| 03/24/2005 | WO2004078941A3 Modulation of gene expression using dna-rna hybrids |
| 03/24/2005 | WO2004078756A3 Jnk inhibitors |
| 03/24/2005 | WO2004078145A3 Combination therapy with glatiramer acetate and simvastatin for the treatment of multiple sclerosis |
| 03/24/2005 | WO2004075834A3 Stabilized pharmaceutical compositions of safingol and methods of using the same |
| 03/24/2005 | WO2004075832A3 Methods and compositions for the treatment of chronic pain using dhea and derivatives thereof |
| 03/24/2005 | WO2004074249A3 Synthesis of peloruside a and analogs thereof for use as antitumor agents |
| 03/24/2005 | WO2004073643A3 Estradiol metabolites for the treatment of pulmonary hypertension |
| 03/24/2005 | WO2004073619A3 Ccr8 antagonists |
| 03/24/2005 | WO2004073608A3 Formulations of glucocorticoids to treat pathologic ocular angiogenesis |
| 03/24/2005 | WO2004072101A3 Phenylglycine derivatives useful as serine protease inhibitors |
| 03/24/2005 | WO2004071426A3 Compounds for the treatment of viral infection |
| 03/24/2005 | WO2004069186A3 Protection against sunburn and skin problems with orally-ingested high-dosage zeaxanthin |
| 03/24/2005 | WO2004069175A3 METHODS AND COMPOSITIONS FOR THE TREATMENT OF PARKINSON’S DISEASE AND OTHER α-SYNUCLEINOPATHIES |
| 03/24/2005 | WO2004069160A3 Chemical compounds |
| 03/24/2005 | WO2004066978A8 Powder pharmaceutical compositions |
| 03/24/2005 | WO2004066956A3 Uses of integrin alphavbeta3 antagonists |
| 03/24/2005 | WO2004064869A3 Amyloid-binding, metal-chelating agents |
| 03/24/2005 | WO2004064789A3 Quaternary antimuscarinic compounds for the treatment of bladder diseases |
| 03/24/2005 | WO2004064788A3 Parenteral formulations of a peptide for the treatment of systemic lupus erythematosus |
| 03/24/2005 | WO2004064730A3 Compounds, compositions and methods |
| 03/24/2005 | WO2004062588A3 Water-soluble polymeric bone-targeting drug delivery system |
| 03/24/2005 | WO2004060882A8 Cb 1/cb 2 receptor ligands and their use in the treatment of pain |
| 03/24/2005 | WO2004060283A3 Nitrosated and nitrosylated rapamycin compounds, compositions and methods of use |
| 03/24/2005 | WO2004052289A3 Multilayered tablet containing pravastatin and aspirin |
| 03/24/2005 | WO2004050072A8 Water-soluble composition containing coenzyme q10 |
| 03/24/2005 | WO2004045508A3 Use of pde4 inhibitors as adjunct therapy for psychiatric disorders |
| 03/24/2005 | WO2004043338A3 Flavin n-oxides: new anti-cancer agents and pathogen eradication agents |
| 03/24/2005 | WO2004041161A3 Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity |
| 03/24/2005 | WO2004040302A8 REGULATION OF INTERACTION BETWEEN RAPL AND Rap1 |